These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In vivo antimalarial evaluation of Gomphostenins.
    Author: Sathe M, Ghorpade R, Srivastava AK, Kaushik MP.
    Journal: J Ethnopharmacol; 2010 Jul 06; 130(1):171-4. PubMed ID: 20452412.
    Abstract:
    AIM OF THE STUDY: The present study aims to evaluate the in vivo antimalarial potential of the leaf extract of Gomphostemma niveum and two new compounds; named as Gomphostenin (GN-6) and acetyl Gomphostenin (GN-10) isolated and purified from this plant against Plasmodium berghei in mice. MATERIALS AND METHODS: The blood schizontocidal activity was performed in early infection of Plasmodium berghei and also in established infection of Plasmodium berghei. The mice were orally administrated with various doses of water and chloroform extracts of leaves of Gomphostemma niveum (GN-W and GN-C, 300, 400 and 500 mg/kg/day), GN-6 and GN-10 (50, 100, 150 and 200mg/kg/day). Chloroquine (8 mg/kg) used as a positive control, while an equal volume of saline plus 0.5% tween-80 was used as a negative control. RESULTS: GN-W, GN-C and pure compounds (GN-6 and GN-10) produced a dose dependent chemosuppression effect at various dose levels. GN-10 exhibited highest percent of chemosuppression i.e. 92.65% at a dose level of 200mg/kg/day. In case of curative test, the survival period of the parasitized infected mice was significantly prolonged at 200mg/kg dose of GN-10. CONCLUSIONS: The studies have indicated that clerodane class of diterpenes GN-6 and GN-10 certainly holds great promise for malaria control and will be useful in antimalarial chemotherapy.
    [Abstract] [Full Text] [Related] [New Search]